Immunogenicity assessment is guided by several regulatory frameworks, including the FDA Final Guidance Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics issued in June 2024
Prices could drop further as more generic versions become available, Saynor said, noting, If you were selling this at $40 or $50 a month, the market could be two or three times bigger in terms of the number of patients. Health Canada taking longer to approve generic drugs, data show Branded weight-loss and diabetes medications, such as Novo Nordisks Ozempic and Wegovy, and Eli Lillys Mounjaro and Zepbound, are currently priced between $200 and $400 for a one-month supply, according to the FT report
To enjoy the e-Newspaper every day, please subscribe.
Trials administering oral or intravenous arginine and citrulline have reported improvements in uteroplacental hemodynamics and gestational blood-pressure control, without documenting teratogenicity or major maternal complications
Patients should be advised that "GLP-1 probiotic" marketing claims are not FDA-evaluated and may be misleading
Garca-Sanmartn J et al